GT005
02.12.21
Gyroscope Therapeutics Announces Positive Interim Data from Phase 1 FOCUS Trial of Investigational Gene Therapy GT005Source: Gyroscope Therapeutics
11.11.20
Gyroscope Therapeutics Announces First Patient Dosed in Phase 2 Trial Evaluating Investigational Gene Therapy for Dry AMDSource: Gyroscope Therapeutics
10.30.20
Gyroscope Therapeutics Announces First Patient Received Investigational Gene Therapy for Dry AMD Via Orbit SDSSource: Gyroscope Therapeutics
09.22.20
Gyroscope Therapeutics Granted FDA Fast Track Designation for Investigational Gene Therapy for Dry AMDSource: Gyroscope Therapeutics
08.13.20
Gyroscope Therapeutics Initiates Phase 2 Program Evaluating its Investigational Gene Therapy for Dry AMDSource: Gyroscope Therapeutics